Laila Kamal, Yuki Kano, Anna-Marie Stevens, Kabir Mohammed, Natalie Pattison, Margaret Perkins, Sanjay Popat, Charlotte Benson, Ollie Minton, Diane Laverty, Theresa Wiseman, Catriona R Mayland, Nicholas Gough, Caroline Williams, Julie Want, Andrew Tweddle, Jayne Wood, Joanne Droney
{"title":"评估皇家马斯登姑息治疗转诊 \"触发器 \"工具对门诊癌症患者的敏感性和可接受性。","authors":"Laila Kamal, Yuki Kano, Anna-Marie Stevens, Kabir Mohammed, Natalie Pattison, Margaret Perkins, Sanjay Popat, Charlotte Benson, Ollie Minton, Diane Laverty, Theresa Wiseman, Catriona R Mayland, Nicholas Gough, Caroline Williams, Julie Want, Andrew Tweddle, Jayne Wood, Joanne Droney","doi":"10.1007/s00520-024-08921-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the use, acceptability, and experience of a seven-item palliative care referral screening tool in an outpatient oncology setting.</p><p><strong>Methods: </strong>A two-phase convergent parallel mixed-methods study. Patient participants who met any of the \"Royal Marsden Triggers Tool\" criteria were compared with those who did not in terms of demographic data, palliative care needs (Integrated Palliative Outcome Scale, IPOS) and quality of life indicators (EORTC-QLQ-C30). In-depth interviews were carried out with patients and oncology staff about their views and experience of the \"Royal Marsden Triggers Tool\". Qualitative and quantitative data were triangulated at data interpretation.</p><p><strong>Results: </strong>Three hundred forty-eight patients were recruited to the quantitative phase of the study of whom 53% met at least one of the Triggers tool palliative care referral criteria. When compared with patients who were negative using the Triggers tool, \"Royal Marsden Triggers Tool\" positive patients had a lower quality of life (EORTC QLQ-C30 Global Health Status scale (p < 0.01)) and a higher proportion had severe or overwhelming physical needs on IPOS (38% versus 20%, p < 0.001). Median survival of \"Royal Marsden Triggers Tool\" positive patients was 11.7 months. Sixteen staff and 19 patients participated in qualitative interviews. The use of the tool normalised palliative care involvement, supporting individualised care and access to appropriate expertise.</p><p><strong>Conclusion: </strong>The use of a palliative care referral tool streamlines palliative care within oncology outpatient services and supports teams working together to provide an early holistic patient-centred service. Further research is needed to evaluate the effectiveness and feasibility of this approach.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"32 11","pages":"730"},"PeriodicalIF":2.8000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485094/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessing the sensitivity and acceptability of the Royal Marsden Palliative Care Referral \\\"Triggers\\\" Tool for outpatients with cancer.\",\"authors\":\"Laila Kamal, Yuki Kano, Anna-Marie Stevens, Kabir Mohammed, Natalie Pattison, Margaret Perkins, Sanjay Popat, Charlotte Benson, Ollie Minton, Diane Laverty, Theresa Wiseman, Catriona R Mayland, Nicholas Gough, Caroline Williams, Julie Want, Andrew Tweddle, Jayne Wood, Joanne Droney\",\"doi\":\"10.1007/s00520-024-08921-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To evaluate the use, acceptability, and experience of a seven-item palliative care referral screening tool in an outpatient oncology setting.</p><p><strong>Methods: </strong>A two-phase convergent parallel mixed-methods study. Patient participants who met any of the \\\"Royal Marsden Triggers Tool\\\" criteria were compared with those who did not in terms of demographic data, palliative care needs (Integrated Palliative Outcome Scale, IPOS) and quality of life indicators (EORTC-QLQ-C30). In-depth interviews were carried out with patients and oncology staff about their views and experience of the \\\"Royal Marsden Triggers Tool\\\". Qualitative and quantitative data were triangulated at data interpretation.</p><p><strong>Results: </strong>Three hundred forty-eight patients were recruited to the quantitative phase of the study of whom 53% met at least one of the Triggers tool palliative care referral criteria. When compared with patients who were negative using the Triggers tool, \\\"Royal Marsden Triggers Tool\\\" positive patients had a lower quality of life (EORTC QLQ-C30 Global Health Status scale (p < 0.01)) and a higher proportion had severe or overwhelming physical needs on IPOS (38% versus 20%, p < 0.001). Median survival of \\\"Royal Marsden Triggers Tool\\\" positive patients was 11.7 months. Sixteen staff and 19 patients participated in qualitative interviews. The use of the tool normalised palliative care involvement, supporting individualised care and access to appropriate expertise.</p><p><strong>Conclusion: </strong>The use of a palliative care referral tool streamlines palliative care within oncology outpatient services and supports teams working together to provide an early holistic patient-centred service. Further research is needed to evaluate the effectiveness and feasibility of this approach.</p>\",\"PeriodicalId\":22046,\"journal\":{\"name\":\"Supportive Care in Cancer\",\"volume\":\"32 11\",\"pages\":\"730\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485094/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Supportive Care in Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00520-024-08921-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Supportive Care in Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00520-024-08921-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Assessing the sensitivity and acceptability of the Royal Marsden Palliative Care Referral "Triggers" Tool for outpatients with cancer.
Purpose: To evaluate the use, acceptability, and experience of a seven-item palliative care referral screening tool in an outpatient oncology setting.
Methods: A two-phase convergent parallel mixed-methods study. Patient participants who met any of the "Royal Marsden Triggers Tool" criteria were compared with those who did not in terms of demographic data, palliative care needs (Integrated Palliative Outcome Scale, IPOS) and quality of life indicators (EORTC-QLQ-C30). In-depth interviews were carried out with patients and oncology staff about their views and experience of the "Royal Marsden Triggers Tool". Qualitative and quantitative data were triangulated at data interpretation.
Results: Three hundred forty-eight patients were recruited to the quantitative phase of the study of whom 53% met at least one of the Triggers tool palliative care referral criteria. When compared with patients who were negative using the Triggers tool, "Royal Marsden Triggers Tool" positive patients had a lower quality of life (EORTC QLQ-C30 Global Health Status scale (p < 0.01)) and a higher proportion had severe or overwhelming physical needs on IPOS (38% versus 20%, p < 0.001). Median survival of "Royal Marsden Triggers Tool" positive patients was 11.7 months. Sixteen staff and 19 patients participated in qualitative interviews. The use of the tool normalised palliative care involvement, supporting individualised care and access to appropriate expertise.
Conclusion: The use of a palliative care referral tool streamlines palliative care within oncology outpatient services and supports teams working together to provide an early holistic patient-centred service. Further research is needed to evaluate the effectiveness and feasibility of this approach.
期刊介绍:
Supportive Care in Cancer provides members of the Multinational Association of Supportive Care in Cancer (MASCC) and all other interested individuals, groups and institutions with the most recent scientific and social information on all aspects of supportive care in cancer patients. It covers primarily medical, technical and surgical topics concerning supportive therapy and care which may supplement or substitute basic cancer treatment at all stages of the disease.
Nursing, rehabilitative, psychosocial and spiritual issues of support are also included.